Women in polluted areas at higher risk of cardiovascular disease


Women living in areas with higher levels of air pollution have a greater risk of developing cardiovascular disease and subsequently dying from cardiovascular causes, according to a study published in The New England Journal of Medicine ( NEJM ).
The study is one of the largest of its kind, involving more than 65,000 Women's Health Initiative Observational Study participants, age 50 to 79, living in 36 cities across the United States.

Researchers studied women who did not initially have cardiovascular disease, following them for up to nine years to see who went on to have a heart attack, stroke, or coronary bypass surgery, or died from cardiovascular causes. They linked this health information with the average outdoor air pollution levels near each woman's home, and found that higher pollution levels posed a significant hazard for development of cardiovascular disease.

The researchers studied levels of fine particulate matter, which are tiny airborne particles of soot or dust, and can come from a variety of sources, like vehicle exhaust, coal-fired power plants, industrial sources, and wood-burning fireplaces. These particles are less than 2.5 microns in diameter. Particulate matter levels are monitored and regulated by the U.S. Environmental Protection Agency ( EPA ). They're typically invisible to the human eye once they're in the atmosphere, though they may be visible in dense clouds as they come out of a tailpipe, smokestack or chimney, and are responsible for urban haze.

" These soot particles, which are typically created by fossil-fuel combustion in vehicles and power plants, can contain a complex mix of chemicals," explained Joel Kaufman, at University of Washington, and leader of the study. " The tiny particles – and the pollutant gases that travel along with them – cause harmful effects once they are breathed in."

Fine particulate matter is measured in micrograms ( or millionths of a gram ) per cubic meter; cities in the study had average levels of fine particulate matter ranging from about 4 to nearly 20 micrograms per cubic meter. The researchers found that each 10-unit increase in fine particulate matter level was linked to a 76 percent increase in the risk of death from cardiovascular disease, after taking into account known risk factors such as blood pressure, cholesterol, and smoking. Higher long-term average levels of fine particulate matter also led to a higher overall risk of cardiovascular disease events, including stroke and myocardial infarction.

They also found that local differences in particulate matter levels within a city, as well as exposure differences between cities, translate to a higher or lower risk of cardiovascular disease and related death.

Previous studies have found apparent links between airborne particulate matter and cardiovascular disease, but this study was the first to look specifically at new cases of cardiovascular disease in previously healthy subjects and local air pollution levels within metropolitan areas. Researchers used data from the multi-site Women's Health Initiative Observational Study, which is funded by the National Heart Lung and Blood Institute of the National Institutes of Health ( NIH ), and coordinated through a center based at the Fred Hutchinson Cancer Research Center in Seattle. The EPA and the National Institute of Environmental Health Sciences provided funding for the study of the effects of air pollution.

Researchers don't understand exactly how fine particulate matter may be leading to cardiovascular disease, but some believe that the soot particles are accelerating atherosclerosis, or hardening of the arteries, which is the major precursor of heart disease.

" This could be a cellular and biochemical process that starts in the lung and then proceeds from there into the cardiovascular system," Kaufman explained. " Or it could be that these very small particles actually enter the blood stream through vessels in the lung, and then begin affecting blood vessels throughout the body."

Source: University of Washington, 2007

XagenaMedicine2007


Link: Xapedia - Medical Encyclopedia